Effects of the addition of gemcitabine,and paclitaxel-first sequencing,in neoadjuvant sequential epirubicin,cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Effects of the addition of gemcitabine,and paclitaxel-first sequencing,in neoadjuvant sequential epirubicin,cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

摘要：
本文献已被 ScienceDirect 等数据库收录！